LEVI STRAUSS & CO
LEVIAbout the company
Levi Strauss & Co. designs, markets, and sells apparels and related accessories for men, women, and children in the United States and internationally. The company offers jeans, casual and dress pants, activewears, tops, shorts, skirts, dresses, jumpsuits, shirts, sweaters, jackets, footwear, and related accessories under the Levi's, Levi Strauss Signature, Denizen, and Beyond Yoga brands.
Investment snapshot
Positive
5
BUY / PASS
Neutral / negative
6 / 4
NEUTRAL / FAIL
Median fair value
$13.64
-30.9% vs price
Models with upside
1 / 16
Positive margin of safety
Strongest signal
9 of 11 pass — Lynch and Akre object
Key risk
Split decision: 6 NEUTRAL · 4 FAIL · 3 PASS · 2 BUY
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
| Metric | O'Shaughnessy Systematic Factor Composite | Lynch GARP | Buffett Quality Compounder | Pabrai Dhandho Framework | Akre Three-Legged Stool | Schloss Asset-Value Discipline | Neff Low-P/E Total Return | Sleep Scale Economies Shared | Templeton Global Bargain Hunter | Marks Risk-Aware Value | Munger Quality Focus | Ackman Activist Value | Dreman Contrarian Value | Piotroski F-Score | Greenblatt Magic Formula | Graham Defensive Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | PASS | NEUTRAL | FAIL | NEUTRAL | NEUTRAL | BUY | NEUTRAL | NEUTRAL | BUY | PASS | PASS | NEUTRAL | BUY · Rank #255 (Top 7.9%) | FAIL |
| Score | ||||||||||||||||
| Analysis | ||||||||||||||||
| Intrinsic Value | N/A | N/A | N/A | N/A | N/A | |||||||||||
| Margin of Safety | N/A | -656.7% | -15.6% | -42.7% | +67.8% | N/A | N/A | N/A | -34.6% | -58.9% | -18.4% | -70.8% | -52.5% | N/A | -131.5% | -44.8% |
| Data As Of | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-24) | 10-K (2026-08-24) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) |
Where It Passes
- Debt & Leverage82% pass✓ 11✗ 3▾
9 of 11 pass — Lynch and Akre object
Debt Levels0.46✗AkreDebt/Equity < 0.3✓MungerDebt/Equity < 0.5Total Debt / Equity0.46✗Lynch< 0.33Cash - Long-term Debt$-281.3M✗LynchPositive preferredDebt/Equity & Interest CoverageD/E: 0.46, IC: 18.3x✓BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Shareholders' Equity0.46x✓SchlossD/E < 1.00x✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓Dreman< 0.8Current Assets / Current Liabilities1.55x✓SchlossCurrent ratio >= 1.50x (app cutoff)✓Dreman> 1.5Interest Coverage & Debt/EBITDAIC=18.3x, D/EBITDA=1.2x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.46✓Ackman<= 1.0LT Debt / Total Assets Change15.59% -> 15.17%✓PiotroskiDecreased YoYLT Debt vs Net Current AssetsLT Debt $1.0B vs NCA $1.1B✓GrahamLT Debt <= Net Current Assets - Efficiency63% pass✓ 8✗ 3▾
5 of 8 pass — Akre, Piotroski and Graham object
ROIC (3-5 yr avg)18.0%✓Buffett> 10%ROIC - WACC+8.0%✓BuffettPositive (WACC = 10%)ROIC (high and growing)FY2023: ROIC=9.1%; FY2024: ROIC=7.0%; FY2025: ROIC=16.1%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC10.2% (RR=63% x ROIC=16.1%)✓AkreReinvestment Rate * ROIC > 10%ROIC (5-year)3/5 years above 12% (latest 16.1%)✓SleepROIC > 12% in a majority of yearsReturn on Invested Capital16.1%✓Munger> 15%Current Assets / Current Liabilities1.55✓Dreman> 1.5Current Ratio Change YoY1.42 -> 1.55✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.95x -> 0.92x✗PiotroskiImproved YoYEBIT / (NWC + Net Fixed Assets)64.8%✓Greenblatt> 25%Current Ratio1.55✗Graham>= 2.0 - Verdicts60% pass✓ 6✗ 4▾
Split decision: 6 NEUTRAL · 4 FAIL · 3 PASS · 2 BUY
Overall verdict✗OshaughnessyFAIL (Rank #273/953 (Top 28.6%))✗LynchFAIL (2/7)✓BuffettPASS (5/9)•PabraiNEUTRAL (2/3)✗AkreFAIL (2/6)•SchlossNEUTRAL (5/7)•NeffNEUTRAL (4/6)✓SleepBUY (5/6)•TempletonNEUTRAL (5/8)•MarksNEUTRAL (4/5)✓MungerBUY (4/4)✓AckmanPASS (5/9)✓DremanPASS (5/11)•PiotroskiNEUTRAL (F-Score 7)✓GreenblattRank #255✗GrahamFAIL (3/9)
Where It Falls Short
- Valuation models9% pass✓ 1✗ 10▾
Models split on LEVI at $19.75 — fair values range $2.61–$61.40
Lynch fair value$2.61✗Lynch-656.7% margin vs $19.75Buffett fair value$17.09✗Buffett-15.6% margin vs $19.75Pabrai fair value$13.84✗Pabrai-42.7% margin vs $19.75Akre fair value$61.40✓Akre+67.8% margin vs $19.75Templeton fair value$14.67✗Templeton-34.6% margin vs $19.75Marks fair value$12.43✗Marks-58.9% margin vs $19.75Munger fair value$16.68✗Munger-18.4% margin vs $19.75Ackman fair value$11.56✗Ackman-70.8% margin vs $19.75Dreman fair value$12.95✗Dreman-52.5% margin vs $19.75Greenblatt fair value$8.53✗Greenblatt-131.5% margin vs $19.75Graham fair value$13.64✗Graham-44.8% margin vs $19.75 - Valuation17% pass✓ 5✗ 21▾
10 of 12 flag LEVI's valuation — Oshaughnessy, Lynch, Schloss +7 more
Revenue / market capitalization+0.8265; #1864/5203 (top 35.8%)✗OshaughnessyTop 10% of eligible cross-sectionNet income / market capitalization+7.61%; #928/6251 (top 14.8%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+4.05%; #1699/4487 (top 37.9%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+6.81%; #2423/6203 (top 39.1%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)7.56✗Lynch< 1.0 (ideally < 0.5)P/E or FCF YieldP/E=13.6x, FCF Yield=4.1%✓PabraiP/E < 15 or FCF Yield > 10%Price / Book Value per Share3.46x✗SchlossP/B <= 0.80x (app cutoff)✗Templeton< 1.5x✗Dreman< 1.2xPrice / Tangible Book Value per Share4.38x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+74.3%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Price / Diluted EPS13.6x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E0.33✗Neff> 0.7 (Neff's published traditional edge)Price / EPS13.6x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)✗Dreman< 12xPrice vs. Trailing Low127% of trailing low ($15.59)✗Templeton<= 120% of trailing low (certified split-adjusted live window)P/B or P/E vs. Historical AverageP/E=13.6x, P/B=3.5x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-52.5% (IV=$12.95 vs Price=$19.75)✗Marks>= 20% below intrinsic valueValuation ReasonablenessP/E=13.6x, OE Yield=7.1%✓MungerP/E < 25 or Owner Earnings Yield > 5%Price / FCF per Share25.6x✗Ackman<= 25Price / (CFO / Shares)14.9x✗Dreman< 8xEBIT / Enterprise Value8.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=8.6%, ROC=64.8%✗GreenblattBoth EY > 10% and ROC > 25%Price / 3-yr avg EPS22.9x✗Graham<= 15xPrice-to-Book Ratio3.5x✗Graham<= 1.5xP/E x P/B79.30✗Graham<= 22.5 - Growth25% pass✓ 5✗ 8▾
6 of 8 flag LEVI's growth — Lynch, Neff, Sleep +3 more
Basic earnings-growth PEG (dividends excluded)7.56✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR1.8%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 9.4% vs Rev: 4.1%✗LynchInventory growth < Revenue growth3-5 Year Diluted EPS CAGR1.8% over 4 years✗Neff7%-20% annualizedRevenue growth vs. gross and operating margin trendgross margin 57.5% -> 61.7%, operating margin 6.1% -> 10.8%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR7.1%✓SleepCAGR > 7%5-Year EPS CAGR1.8% CAGR over 4 years✓Templeton> 0% (5-year EPS CAGR)Positive Net Income Frequency26/27 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth3.3%✗Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 yearsEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growth - Profitability27% pass✓ 15✗ 16▾
11 of 15 flag LEVI's profitability — Oshaughnessy, Lynch, Buffett +8 more
Net income / market capitalization+7.61%; #928/6251 (top 14.8%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)7.56✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR1.8%✓Lynch15-30% (Fast Grower); > 0% to passROE25.4%✓Lynch> 15%Net Income Positive (10+ years)26/28 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)22.3%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)10.8% (latest)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$578.1M✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdMargin of SafetyP/E=13.6x, P/B=3.5x✓PabraiP/B < 1.5 or P/E < 15Return on Equity16.1% (3-yr avg)✗AkreROE > 20% (3-year avg)Positive Diluted-EPS Years8/9 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule)3-5 Year Diluted EPS CAGR1.8% over 4 years✗Neff7%-20% annualizedRevenue growth vs. gross and operating margin trendgross margin 57.5% -> 61.7%, operating margin 6.1% -> 10.8%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-Year EPS CAGR1.8% CAGR over 4 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend6.1% (2023) -> 10.8% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsDiscount to Intrinsic Value-52.5% (IV=$12.95 vs Price=$19.75)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency26/27 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue10.8%✗Ackman>= 15%Net Income / Shareholders Equity25.4%✓Ackman>= 15%Pre-Tax Income / Revenue10.1%✓Dreman>= 8%Net Income / Shareholders' Equity25.4%✓Dreman> 12%Net Income / Total Assets8.44%✓PiotroskiROA > 0ROA Change YoY3.30% -> 8.44% (delta: +5.14%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=7.73%, ROA=8.44%✗PiotroskiCFO/Assets > ROAGross Margin Change YoY60.6% -> 61.7%✓PiotroskiImproved YoYEBIT / Enterprise Value8.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=8.6%, ROC=64.8%✗GreenblattBoth EY > 10% and ROC > 25%Positive EPS (10 years)11/28 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growth - Cash Flow50% pass✓ 6✗ 6▾
5 of 10 pass — Oshaughnessy, Lynch, Ackman +2 more object
(Operating cash flow - capex) / market capitalization+4.05%; #1699/4487 (top 37.9%)✗OshaughnessyTop 10% of eligible cross-sectionFCF Positive and Growing$308.2M✗LynchPositive and growingFree Cash Flow Proxy$578.1M✓BuffettPositive and growingP/E or FCF YieldP/E=13.6x, FCF Yield=4.1%✓PabraiP/E < 15 or FCF Yield > 10%Operating Cash Flow - Capital Expenditures$308.2M✓Neff> $0 (app proxy for a strong fundamental case)Positive Operating Cash Flow frequency24/24 years positive✓SleepPositive OCF in >= 70% of available yearsFCF Positive21/24 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap3.9%✗Ackman>= 4%Price / FCF per Share25.6x✗Ackman<= 25Price / (CFO / Shares)14.9x✗Dreman< 8xOperating Cash Flow$529.6M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=7.73%, ROA=8.44%✗PiotroskiCFO/Assets > ROA
Business & financials
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 0.7% of shares last year, 0.5% over two.
- Buybacks
- $30.5M
- Dividends
- $212.9M
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Annual data (10-K) · Last 5 years
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $7.6B | $7.4Best. | $6.1Best. | $6.8Best. | $8.0Best. |
| Revenue | $6.3B↑4% | $6.0B↑3% | $5.8B↓5% | $6.2B↑7% | $5.8B |
| Operating Income | $677.6M↑158% | $262.7M↓26% | $354.4M↓45% | $646.5M↓6% | $686.2M |
| Net Income | $578.1M↑175% | $210.6M↓16% | $249.6M↓56% | $569.1M↑3% | $553.5M |
| EPS (Diluted) | $1.45↑179% | $0.52↓16% | $0.62↓56% | $1.41↑4% | $1.35 |
| Gross Margin | 61.7%↑2% | 60.6%↑5% | 57.5% | 57.5%↓1% | 58.1% |
| Operating Margin | 10.8%↑148% | 4.4%↓28% | 6.1%↓42% | 10.5%↓12% | 11.9% |
| ROE | 25.4%↑137% | 10.7%↓12% | 12.2%↓59% | 29.9%↓10% | 33.2% |
| Total Debt | $1.0B↑4% | $999.5M↓2% | $1.0B↑3% | $996.2M↓3% | $1.0B |
| Shareholders' Equity | $2.3B↑16% | $2.0B↓4% | $2.0B↑7% | $1.9B↑14% | $1.7B |
| Current Ratio | 1.55↑9% | 1.42↓4% | 1.48↑3% | 1.43↓2% | 1.45 |
| Debt / Equity | 0.46↓10% | 0.51↑2% | 0.50↓5% | 0.52↓15% | 0.62 |
| Operating Cash Flow | $529.6M↓41% | $898.4M↑106% | $435.5M↑91% | $228.1M↓69% | $737.3M |
| Free Cash Flow | $308.2M↓54% | $670.9M↑450% | $121.9M↑413% | -$39.0M↓107% | $570.4M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Apparel
LEVI vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CINTAS CORPCTAS | $79.0B | $197.74 | $10.3B | $1.8B | 38.7% | 0.52 | 22.8% | 2.09 | 3/9 | 5/9 | 1/7 | 1/3 | F-Score 5 | 5/11 |
| TAPESTRY, INC.TPR | $22.8B | $114.12 | $7.0B | $183.2M | 21.4% | 2.79 | 5.9% | 1.87 | 1/9 | 3/9 | 1/7 | 0/3 | F-Score 5 | 3/11 |
| Amer Sports, Inc.AS | $15.2B | $27.24 | $6.6B | $427.4M | 7.4% | 0.14 | 10.7% | 1.50 | 2/9 | 3/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| DECKERS OUTDOOR CORPDECK | $10.8B | $77.68 | $5.5B | $1.0B | 41.0% | — | 23.1% | 3.54 | 2/9 | 5/9 | 3/7 | 3/3 | F-Score 7 | 5/11 |
| lululemon athletica inc.LULU | $10.7B | $96.87 | $11.1B | $1.6B | 31.8% | 0.00 | 19.9% | 2.26 | 4/9 | 5/9 | 3/7 | 3/3 | F-Score 4 | 5/11 |
| On Holding AGONON | $9.9B | $29.55 | $3.8B | $257.3M | 12.5% | 0.32 | 12.5% | 2.71 | 2/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| Gildan Activewear Inc.GIL | $7.9B | $42.62 | $3.6B | $398.9M | 11.2% | 1.21 | 17.1% | 2.11 | 3/9 | 5/9 | 1/7 | 0/3 | F-Score 4 | 5/11 |
| Crocs, Inc.CROX | $6.3B | $126.14 | $4.0B | $81.2M | -6.3% | 0.95 | 3.7% | 1.27 | 2/9 | 4/9 | 0/7 | 1/3 | F-Score 5 | 2/11 |